Filter
1913
Filtered Results: 1913
Text search:
therapeutics
committees
Featured
Recommendations
230
New Publications
507
Language
Document type
No document type
1023
Guidelines
318
Studies & Reports
309
Manuals
116
Strategic & Response Plan
75
Training Material
25
Situation Updates
21
Fact sheets
18
Resource Platforms
4
Brochures
2
Infographics
2
Countries / Regions
India
93
Global
77
South Africa
71
Kenya
65
Ethiopia
50
Uganda
46
Sierra Leone
38
Nigeria
36
Western and Central Europe
35
Ghana
30
Nepal
29
Namibia
27
Liberia
27
Rwanda
23
Zambia
23
Latin America and the Carribbean
22
Malawi
21
Bangladesh
21
Tanzania
19
Zimbabwe
18
Africa
18
Germany
18
Myanmar / Burma
18
Congo, Democratic Republic of
16
Lesotho
15
Philippines
15
South Sudan
14
Mozambique
13
Burkina Faso
12
Syria
11
South–East Asia Region
11
Indonesia
11
Guinea
9
Cambodia
9
West and Central Africa
9
East and Southern Africa
9
Eastern Europe
9
Brazil
9
Eswatini/ Swaziland
9
Ukraine
8
Haiti
8
Asia
8
Russia
8
Eastern Europe and Central Asia
7
Pakistan
7
Cameroon
6
Middle East and North Africa
6
Botswana
6
Iraq
5
Colombia
4
Thailand
4
Afghanistan
4
USA
4
Vietnam
4
Sudan
4
Yemen
4
Central African Republic
4
Benin
3
China
3
Fiji
3
Laos
3
Burundi
3
Mali
3
Tajikistan
2
Serbia
2
Albania
2
Singapore
2
Senegal
2
Uzbekistan
2
Armenia
2
Venezuela
2
Lithuania
2
Jordan
2
Western Pacific Region
2
Gabon
2
Mauritius
2
United Kingdom
2
Sri Lanka
2
Poland
2
Angola
2
Libya
2
Bhutan
2
Madagascar
2
North Macedonia
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Estonia
1
Kyrgyzstan
1
Niger
1
Peru
1
Malaysia
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Paraguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Belarus
1
Southern Africa
1
Argentina
1
Papua New Guinea
1
Egypt
1
Romania
1
Georgia
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
772
Clinical Guidelines
177
Key Resources
103
Public Health
98
Women & Child Health
95
Pharmacy & Technologies
28
Capacity Building
20
Toolboxes
Mental Health
166
COVID-19
155
AMR
151
Pharmacy
106
HIV
92
TB
75
Rapid Response
61
NTDs
55
Ebola & Marburg
54
Caregiver
53
NCDs
42
Conflict
42
Disability
40
Refugee
28
Natural Hazards
23
Malaria
20
Global Health Education
18
Planetary Health
17
Health Financing Toolbox
16
Zika
10
Social Ethics
9
Polio
9
Specific Hazards
7
Cholera
6
Today, the World Health Organization (WHO) is advancing the global fight against acute malnutrition in children under 5 with the launch of its new guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition). This milestone is a crucial response to the persistent...
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical...
The Onchocerciasis Control Programme in West Africa (OCP) undertook regional and large scale frght against onchocerciasis in West Africa in 1974 using a vector control strategy. By 2002 OCP had succeeded in eliminating the disease as a public health, socio-economic and development problem in 10 out ...
des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
Recommendations for Diagnosis and Treatment of Nontuberculous Mycobacterioses of the German Central Committee against Tuberculosis and the German Respirator...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
Hendra virus (HeV) continues to pose a serious public health concern as spillover events occur sporadically. Terminally ill horses can exhibit a range of clinical signs including frothy nasal discharge, ataxia or forebrain signs. Early signs, if detected, can include depression, inappetence, colic o...
This casebook collects 64 case studies, each of which raises an important and difficult ethical issue connected with planning, reviewing, or conducting health-related research. The book’s purpose is to contribute to thoughtful analysis of these issues by researchers and members of research ethics ...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities ...
Early Childhood Matters is a journal about early childhood. It looks at specific issues regarding the development of young children, in particular from a psychosocial perspective. It is published twice per year by the Bernard van Leer Foundation.
On Page 54 of this issue the article titled: "Par...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are...
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to support key stakeholders involved in these processes (such as the Cabinet, Ministries of Finance and Healt...
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h...
Community-Based Management of Acute Malnutrition (CMAM) is a decentralised community-based approach to treating acute malnutrition. Treatment is matched to the nutritional and clinical needs of the child, with the majority children receiving treatment at home using ready-to-use foods. In-patient car...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
